18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules
Trial ID or NCT#
NCT03824535
Status
RECRUITING
Purpose
This phase II trial studies how well 18F-FSPG positron emission tomography (PET)/computed tomography (CT) work in diagnosing early lung cancer in patients with lung nodules. PET imaging with an imaging agent called 18F-FDG is often used in combination with a PET/CT scanner to evaluate cancers. Giving 18F-FSPG before a PET/CT scan may work better in helping researchers diagnose early lung cancer in patients with lung nodules.
Official Title
18F-FSPG PET/CT and Integrated Biomarkers for Early Lung Cancer Detection in Patients With Indeterminate Pulmonary Nodules
Eligibility Criteria
Ages Eligible for Study: Older than 45 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Pulmonary nodule between the size of 7 to 30 mm. Subjects with multiple nodules may be eligible if the dominant nodule is 7 to 30 mm - Undergoing standard of care 18F-FDG PET imaging (for indeterminate pulmonary nodule) - Current or former cigarette smoker, with >= 20 pack years - Documented informed consent
Exclusion Criteria:
- - History or previous diagnosis of lung cancer - Cancer diagnosis within the last 5 years - Pregnant or nursing
Investigator(s)
Sanjiv Sam Gambhir, MD, PhD
Contact us to find out if this trial is right for you.
Contact
Mahima Goel
650-723-0371
View on ClinicalTrials.gov
